Your session is about to expire
← Back to Search
Telehealth tDCS + Mindfulness for Cannabis Use Disorder
Study Summary
This trial will test whether a brain stimulation technique can help people with MS who also use cannabis heavily and have high levels of distress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 54 Patients • NCT01726673Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are trying to stop or cut back on using marijuana in any form (smoking, vaping, or eating).I have had seizures or a seizure disorder in the last 5 years.I do not have a current diagnosis of severe mental health conditions like schizophrenia or bipolar disorder.My medications have been the same for at least a month.I understand and agree to participate in the study.I am using medical marijuana as prescribed by my doctor.I have had an MS flare-up or used high-dose steroids recently.I can use smartphones or tablets.I have been diagnosed with relapsing-remitting multiple sclerosis.I have mild to moderate neurological disability but can complete required procedures.I have metal implants in my head or neck.I am between 21 and 65 years old and want to cut down or stop using cannabis.I have skin issues near where a medical device would be placed.I do not have a major neurological, psychiatric, or other medical condition besides MS.I am between 21 and 65 years old.We will provide you with stable and continuous access to internet service, as well as email access through a WiFi hotspot if needed.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to participate in this clinical trial?
"This clinical trial is accepting 46 patients of between 21 and 65 years of age, who have been diagnosed with Multiple sclerosis. The prerequisites for this study are a K10 score from 10 to 35 (mild to high moderate distress), PDDS scores ranging from 0-7 (corresponding to mild to moderate neurological impairment as determined by their capacity for the required procedures). Additionally, it is essential that all medications remain stable during both the month prior enrolment and throughout the duration of the trial; participants must also be able provide evidence that they possess reliable internet access and can operate mobile devices."
What is the cap on enrollment for this clinical trial?
"Indeed, the clinicaltrials.gov site indicates that this trial is actively recruiting as of November 3rd 2022. The study was first posted on August 13th, and it wants to enroll 46 patients from one location."
Are geriatric individuals being included in the scope of this medical investigation?
"This trial is open to participants aged 21-65. However, there are 59 studies available for those under the legal age of consent and 442 trials that cater to seniors over 65 years old."
Is the recruitment of participants still ongoing for this experiment?
"Clinicaltrials.gov data signifies that this research venture is actively seeking enrolments, having been initially posted on August 13th 2022 and most recently updated November 3rd of the same year."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger